Novo Nordisk, the Danish giant known for its groundbreaking obesity drugs, has announced the acquisition of Akero Therapeutics for an astonishing $5.2 billion. The main goal behind the deal is access to one of the most promising drugs for MASH (Metabolic Dysfunction-Associated Steatohepatitis).
The Indian surgical robot Mizzo Endo 4000 may not be the work of local engineers at all. A rival company has accused the robot’s manufacturers of importing equipment from China under the guise of local production.
American company Vektor Medical has received the prestigious CE mark for its non-invasive cardiac arrhythmia mapping system, vMap. This allows them to plan their expansion into the European Union and use artificial intelligence to diagnose heart arrhythmias.
Scientists have managed to engineer viruses that can infect only specific bacteria. This discovery opens up vast opportunities for medical innovation through new forms of therapy — but it also raises serious concerns about potential misuse, including the development of biological weapons.